Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @KitePharma
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @KitePharma
-
"As we look ahead to the next 30 years, there is reason to be more energized than ever about the path forward." - Kite CEO Christi Shaw on
#WorldCancerDay
. #IAmAndIWill
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What is the bravest thing we can do about
#cancer? Come together, says Kite CEO Christi Shaw.#WorldCancerDay
#IAmAndIWill
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We all know someone who has been affected by
#cancer. On February 4, join us in raising awareness by sharing how you’re committed to reducing the impact of the disease.#WorldCancerDay
#IAmAndIWill
@uiccpic.twitter.com/mShKouYzPVHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are pleased to join
@EHA_Hematology and@TheEBMT at the 2nd European CAR T Cell Meeting in Sitges, Spain this week to discuss the latest research in#celltherapypic.twitter.com/BvVWruCm9j
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today the Marketing Authorization Application for our second
#CARTcell therapy was validated for review by the European Medicines AgencyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We were honored to attend
@PhRMA’s Researcher Day in Maryland today and discuss the future of#celltherapypic.twitter.com/nHIefPGNsu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK: Engineered TCR therapies are currently being investigated for the potential treatment of various solid tumors and blood cancers?pic.twitter.com/FVMgrSdnBM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our team in Amsterdam (Hoofddorp) is growing! See what a day in the life of a Cell Therapy Specialist (CTS) there looks like.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Celltherapy manufacturing is a unique and highly scientific process that requires continual innovation and rapid turnaroundpic.twitter.com/8N1d7UKs5N
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
What a year! We’re ringing in the New Year with excitement as we continue to drive
#celltherapy forward. See you in 2020!#HappyNewYearHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At Kite, we’re advancing
#CARTcell technology. Take a closer look at how#celltherapy works.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kite employees helped spread holiday cheer by donating toys for underserved children and teens in the Southern California area today.
#StuffTheBus#SparkOfLove@abc7@LACOFD@WeDriveUpic.twitter.com/SCLbPW9adyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We were honored to host the Women at Gilead SoCal Chapter’s Career Development and Networking Event with Kimberly Lathroum (
@kitepharma),@BDahiyat and@DinaAtUCLATDG at our Kite headquarters in Santa Monica last night.#STEM#healthcarepic.twitter.com/zqbFBSCyA9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Kite and
@Kiniksa announce clinical collaboration in relapsed or refractory large B-cell#lymphoma: https://www.gilead.com/news-and-press/press-room/press-releases/2019/12/kite-and-kiniksa-pharmaceuticals-announce-clinical-collaboration-evaluating-investigational-combination-of-yescarta-and-mavrilimumab-in-relapsed-or-r …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19 has come to an end, but there’s still more to come from us. Keep following along on Twitter for more on our advancing#celltherapy portfolio!pic.twitter.com/WsiYX779fRHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to everyone who stopped by our booth to learn about Kite’s pipeline in
#celltherapy at#ASH19pic.twitter.com/b5ONv7J04S
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.